Semnur Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-426.1K | $-426.1K | — | — |
| FY2023 | $-632.8K | $-632.8K | — | — |
| FY2024 | $-4.9M | $-4.9M | — | $660.0K |
| FY2025 | $-5.9M | $-5.9M | — | $142.4M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-426.1K | $-426.1K | — | — |
| FY2023 | $-632.8K | $-632.8K | — | — |
| FY2024 | $-4.9M | $-4.9M | — | $660.0K |
| FY2025 | $-5.9M | $-5.9M | — | $142.4M |